Table 6 TP53 overlapping cluster membership
From: Pathway Distiller - multisource biological pathway consolidation
Pathway Name, (enrichment p-value) | HPD similarity grouping | de novo Gene Membership | de novo Gene Ontology | de novo Protein Interactants |
|---|---|---|---|---|
G1 to S cell cycle control (p = 7.30 × 10-3) | ■ | ■ | ■ | ■ |
G2_PATHWAY (p = 2.58 × 10-3) | ▲ | ▲ | ■ | ■ |
Class I PI3K signaling events mediated by AKT (p = 0.14) | ● | ▼ | ▲ | ■ |
DNA damage response (p = 7.20 × 10-3) | ● | ● | ▲ | ■ |
MAPK signaling pathway (p = 2.88 × 10-2) | ● | ► | ▲ | ■ |
Glioma (p = 6.70 × 10-3) | ► | ► | ▲ | ■ |
Non-small cell lung cancer (p = 5.80 × 10-3) | ► | ► | ▲ | ■ |
Melanoma (p = 7.63 × 10-3) | ► | ► | ▲ | ■ |
Endometrial Cancer (p = 5.59 × 10-3) | ► | ► | ▲ | ■ |